STAT3 and neoplasm: Results from these in vivo experiments clearly showed that while control cells initiated tumors in 100% (2×104) and 50% (1×104) of injection sites, STAT3-silenced cells initiated a tumor only in 19% and 6% of the cases, respectively (Figure 6A and B).